1. Home
  2. LHSW vs CRBP Comparison

LHSW vs CRBP Comparison

Compare LHSW & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LHSW
  • CRBP
  • Stock Information
  • Founded
  • LHSW 2007
  • CRBP 2009
  • Country
  • LHSW China
  • CRBP United States
  • Employees
  • LHSW N/A
  • CRBP N/A
  • Industry
  • LHSW
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LHSW
  • CRBP Health Care
  • Exchange
  • LHSW NYSE
  • CRBP Nasdaq
  • Market Cap
  • LHSW 81.6M
  • CRBP 73.4M
  • IPO Year
  • LHSW 2025
  • CRBP N/A
  • Fundamental
  • Price
  • LHSW $2.31
  • CRBP $7.34
  • Analyst Decision
  • LHSW
  • CRBP Strong Buy
  • Analyst Count
  • LHSW 0
  • CRBP 10
  • Target Price
  • LHSW N/A
  • CRBP $53.56
  • AVG Volume (30 Days)
  • LHSW 883.8K
  • CRBP 114.6K
  • Earning Date
  • LHSW 01-01-0001
  • CRBP 05-06-2025
  • Dividend Yield
  • LHSW N/A
  • CRBP N/A
  • EPS Growth
  • LHSW N/A
  • CRBP N/A
  • EPS
  • LHSW 0.05
  • CRBP N/A
  • Revenue
  • LHSW $36,718,017.00
  • CRBP N/A
  • Revenue This Year
  • LHSW N/A
  • CRBP N/A
  • Revenue Next Year
  • LHSW N/A
  • CRBP $150.00
  • P/E Ratio
  • LHSW $48.49
  • CRBP N/A
  • Revenue Growth
  • LHSW 24.85
  • CRBP N/A
  • 52 Week Low
  • LHSW $0.99
  • CRBP $4.64
  • 52 Week High
  • LHSW $8.18
  • CRBP $61.90
  • Technical
  • Relative Strength Index (RSI)
  • LHSW N/A
  • CRBP 52.51
  • Support Level
  • LHSW N/A
  • CRBP $7.05
  • Resistance Level
  • LHSW N/A
  • CRBP $7.62
  • Average True Range (ATR)
  • LHSW 0.00
  • CRBP 0.49
  • MACD
  • LHSW 0.00
  • CRBP -0.02
  • Stochastic Oscillator
  • LHSW 0.00
  • CRBP 42.65

About LHSW LIANHE SOWELL INTERNATIONAL GROUP L

Lianhe Sowell International Group Ltd is a holding company and operates its business through its subsidiary. It is a provider of machine vision products and solutions in China that invent and integrate technologies and solutions that address some of the most critical manufacturing and distribution challenges, such as precision and accuracy required in manufacturing of electronic products. The company categorize machine vision products in four categories based on their application settings: Industrial Machine Vision, Artificial Intelligence (Face Recognition and AI Behavior Analysis), Intelligent Weak Current (Building Intelligence and Intelligent Transportation) and Electronic Customs Clearance.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: